These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6440806)

  • 1. Pulmonary gold toxicity.
    Morley TF; Komansky HJ; Adelizzi RA; Giudice JC
    Eur J Respir Dis; 1984 Nov; 65(8):627-32. PubMed ID: 6440806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse pulmonary injury associated with gold treatment.
    Winterbauer RH; Wilske KR; Wheelis RF
    N Engl J Med; 1976 Apr; 294(17):919-21. PubMed ID: 130554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of gold-induced pneumonitis showing a positive reaction in the drug lymphocyte stimulation test (DLST) for gold].
    Bando M; Takishita Y; Bando H; Hashimoto Y; Sano T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):128-32. PubMed ID: 1625388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pneumonitis as a consequence of gold therapy].
    Skralovnik-Stern A; Glücks A; Stern A; Remskar J; Simcić A
    Plucne Bolesti; 1986; 38(3-4):248-52. PubMed ID: 3108913
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Pulmonary reaction to chrysotherapy.
    N Engl J Med; 1976 Aug; 295(9):506-7. PubMed ID: 820998
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gold-induced fibrosing lung disease--3 cases].
    Tomioka M; Sato S; Kikuchi R; Maeda S; Aoki T; Nagaoka Y; Shimura S; Takishima T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1982 May; 20(5):590-6. PubMed ID: 6813547
    [No Abstract]   [Full Text] [Related]  

  • 7. [Case report and literature analysis of the clinical factors relating to the development of fibrotic changes in gold lung].
    Aoshiba K; Fukuda I; Mochizuki M; Tamaoki J; Konno K; Takizawa T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):336-43. PubMed ID: 2113147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse pulmonary injury associated with gold therapy.
    Scharf J; Nahir M; Kleinhaus U; Barzilai D
    JAMA; 1977 May; 237(22):2412. PubMed ID: 404444
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pulmonary infiltrates associated with gold therapy].
    Tala E; Jalava S; Nurmela T; Vuori K
    Duodecim; 1979; 95(1):30-4. PubMed ID: 104857
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe pseudomembranous and ulcerative colitis during gold therapy.
    Reinhart WH; Kappeler M; Halter F
    Endoscopy; 1983 Mar; 15(2):70-1. PubMed ID: 6406212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A fatal case of pemphigus vulgaris with interstitial pneumonia occurring during gold therapy].
    Usuba Y; Aiba S; Hashimoto K; Tanita Y; Sakai K
    Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):725-30. PubMed ID: 2511359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypogammaglobulinemia and lung infiltrates after gold therapy.
    Stuckey BG; Hanrahan PS; Zilko PJ; Owen ET
    J Rheumatol; 1986 Apr; 13(2):468-9. PubMed ID: 3088277
    [No Abstract]   [Full Text] [Related]  

  • 13. Alveolar macrophage gold retention in rheumatoid arthritis.
    Garcia JG; Munim A; Nugent KM; Bishop M; Hoie-Garcia P; Parhami N; Keogh BA
    J Rheumatol; 1987 Jun; 14(3):435-8. PubMed ID: 3114483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver dysfunction associated with gold therapy for rheumatoid arthritis.
    Edelman J; Donnelly R; Graham DN; Percy JS
    J Rheumatol; 1983 Jun; 10(3):510-1. PubMed ID: 6411922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [T-lymphocytosis and lymphokines in bronchoalveolar lavage fluid of a gold salt-induced pneumonitis].
    Ikeda S; Chikazawa C; Naoe H; Manba K; Yasuda K; Yastake T; Honda M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Nov; 24(11):1258-65. PubMed ID: 3104641
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fatal pulmonary fibrosis caused by gold therapy?].
    Chatzigiannis I; Schmidt KL; Stambolis C
    Z Rheumatol; 1984; 43(2):49-58. PubMed ID: 6428074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of gold and penicillamine therapy to diffuse interstitial lung disease.
    Scott DL; Bradby GV; Aitman TJ; Zaphiropoulos GC; Hawkins CF
    Ann Rheum Dis; 1981 Apr; 40(2):136-41. PubMed ID: 6784683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HLA DR7 as a protective factor against gold salt toxicity in rheumatoid arthritis].
    Rodríguez Pérez M; González Domínguez J; Matarán Pérez L; Salvatierra Ríos D
    An Med Interna; 1993 Oct; 10(10):484-6. PubMed ID: 8136425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.